DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Mercure Hotel Amsterdam City

2019 年 12 月 04 日 8:00 上午 - 2019 年 12 月 05 日 5:00 下午

Joan Muyskenweg 10, 1096 CJ Amsterdam, Netherlands

Clinical Trial Disclosure & Data Transparency Conference

Evolving Requirements and New Challenges

Session 7: Lay Summaries and Regulatory

Session Chair(s)

Caragh  Murray

Caragh Murray

Plain Language Summary Manager, Data Transparency, Janssen Research & Development, United Kingdom

Lay Summaries are required for all studies sponsors will run in the EU after the EU CTR effective date. Sponsors have begun implementation and many early successes have led to lessons learned in delivery. In this session sponsors with different perspectives will present their experiences to date through a panel discussion. Objectives: •Discuss experience in the implementation for each sponsor •Share lessons learned during the implementation as early adopters •Discuss key topics that have presented a challenge during the implementation •Discuss current hot topics sponsors are facing during their implementation journeys

Speaker(s)

D.K.Theo  Raynor, PHD, MPHARM

D.K.Theo Raynor, PHD, MPHARM

Professor of Pharmacy Practice, University of Leeds, United Kingdom

User Testing Perspective

Anne  Cutting

Anne Cutting

Director, Human Subject Research Governance, GSK, United Kingdom

Industry Perspective

Tomas  Rees, PHD

Tomas Rees, PHD

Communications Director , Oxford PharmaGenesis, United Kingdom

Medical Writing Perspective

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。